Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. Cancers 2020, 12, 3419

Cancers (Basel). 2021 Jun 22;13(13):3104. doi: 10.3390/cancers13133104.

Nuria Dueñas^{1

2}, Matilde Navarro^{1

2

3}, Àlex Teulé¹, Ares Solanes³, Mònica Salinas^{1

2}, Sílvia Iglesias^{1

2}, Elisabet Munté¹, Jordi Ponce⁴, Jordi Guardiola⁵, Esther Kreisler⁶, Elvira Carballas⁷, Marta Cuadrado⁸, Xavier Matias-Guiu⁹, Napoleón de la Ossa^{10

11}, Joan Lop¹², Conxi Lázaro^{1

2}, Gabriel Capellá^{1

2}, Marta Pineda^{1

2}, Joan Brunet^{1

2

13}

¹ Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
² Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.
³ Hereditary Cancer Program, Catalan Institute of Oncology, 08916 Badalona, Barcelona, Spain.
⁴ Department of Gynecology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
⁵ Department of Gastroenterology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
⁶ Department of General Surgery, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
⁷ Department of Gynecology, Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
⁸ Department of General Surgery, Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
⁹ Department of Pathology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
¹⁰ Department of Pathology, Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
¹¹ Department of Pathology, Hospital General de Catalunya-Grupo Quironsalud, 08203 Barcelona, Spain.
¹² Department of Pathology, Hospital del Mar Institute for Medical Research, 08003 Barcelona, Spain.
¹³ Hereditary Cancer Program, Catalan Institute of Oncology-IDBIGI, 17007 Girona, Spain.

Abstract